» Articles » PMID: 39691248

Clinical Significance of Philadelphia-like-related Genes in a Resource-constrained Setting of Adult B-acute Lymphoblastic Leukemia Patients

References
1.
Roberts K . The biology of Philadelphia chromosome-like ALL. Best Pract Res Clin Haematol. 2017; 30(3):212-221. DOI: 10.1016/j.beha.2017.07.003. View

2.
Gestrich C, De Lancy S, Kresak A, Meyerson H, Pateva I, Yalley A . IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemia. Br J Haematol. 2023; 204(1):229-239. DOI: 10.1111/bjh.19142. View

3.
den Boer M, van Slegtenhorst M, de Menezes R, Cheok M, Buijs-Gladdines J, Peters S . A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2):125-34. PMC: 2707020. DOI: 10.1016/S1470-2045(08)70339-5. View

4.
Gupta D, Varma N, Kumar A, Naseem S, Sachdeva M, Binota J . PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of -like acute lymphoblastic leukaemia in Indian patients. Leuk Lymphoma. 2021; 63(3):633-643. DOI: 10.1080/10428194.2021.1999439. View

5.
Biondi A, Schrappe M, De Lorenzo P, Castor A, Lucchini G, Gandemer V . Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. Lancet Oncol. 2012; 13(9):936-45. PMC: 3431502. DOI: 10.1016/S1470-2045(12)70377-7. View